Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2026-03-29 @ 11:49 PM
Study NCT ID:
NCT02715804
Status:
TERMINATED
Last Update Posted:
2020-07-14
First Post:
2016-03-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma
Sponsor:
Halozyme Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03-14
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-11-04
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-17
First Submit QC Date:
None
Study First Post Date:
2016-03-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-06-11
Results First Submit QC Date:
None
Results First Post Date:
2020-07-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-06-30
Last Update Post Date:
2020-07-14
Last Update Post Date Type:
ACTUAL